# AIDOT

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aidot

- Industry: Healthcare IT
- Headquarters: Seoul, South Korea
- Website: www.aidot.ai
- Total disclosed funding: $2.5M
- Latest round: Series A (Aug 20, 2021)
- Investors on record: 2

## About

Based in Seoul, South Korea, and founded in 2014, AIDOT Inc. operates as a medical software development company that offers a suite of health tech solutions that include an image processing-based artificial intelligence cervical cancer screening and reading system. In 2016, the company was selected by K-Global Startup Competition for its Deep Learning-based Next-Generation Reading System. AIDOT Inc. received a commendation from the Minister of Science and ICT followed by the signing of a joint research contract with Seoul National University Bundang Hospital in 2017. The company established a joint corporation in Changsha, Hunan, China Completed the main contract with China Zhong and Low Group the following year and completed its medical device import business license from the Ministry of Food and Drug Safety in 2019.

The company develops and operates Cerviray AI, an AI-based cervical cancer screening system, a carotid artery plaque screening AI used for stroke risk detection named SONO AI system, an AI-based Cerebral Aneurysm Rupture Risk Detection Software called NAO AI system, and Gastrointestinal endoscopy AI, a real-time detection and diagnosis system.

AIDOT Inc. plans to grow into a company that sets a good example for the development of the domestic medical artificial intelligence industry.

## Funding rounds

- Series A, Aug 20, 2021, $2.5M — Korea Investment & Securities, Findvalue Asset Management

## Investors

- Korea Investment & Securities (https://capitalatlas.ai/funds/korea-investment-securities) — Series A
- Findvalue Asset Management (https://capitalatlas.ai/funds/findvalue-asset-management) — Series A